Social media

Multiple sclerosis affects nearly one million people in the U.S., and the way it’s studied and treated is changing. New ICD 10 subtype codes and evolving treatment strategies are enabling more precise real world insight...

The U.S. multiple sclerosis treatment landscape is evolving—shifting from relapse suppression toward addressing disability progression in progressive forms of MS. New ICD 10 subtype codes, introduced in October 2025, ma...

Flow cytometry is evolving faster than ever—reshaping how the industry approaches assay development, validation, and clinical trial execution. ICON’s Thanh-Long Nguyen will join the upcoming Bioanalysis Zone panel to exp...

Flow cytometry is evolving faster than ever—reshaping how the industry approaches assay development, validation, and clinical trial execution. ICON’s long Nguyen will join the upcoming Bioanalysis Zone panel to explore t...

Europe’s Health Technology Assessment Regulation officially went live in January 2025, marking a major shift toward harmonised JCAs and JSCs. What did we learn in year one? - The scale is growing fast – the number of JC...

Europe’s Health Technology Assessment Regulation officially went live in January 2025, marking a major shift toward harmonised JCAs and JSCs. What did we learn in year one? - The scale is growing fast – the number of JC...

Long‑acting injectables have reshaped HIV treatment, but they still fall short of overcoming the fundamental limitations of ART. Our latest article explores how next‑generation approaches are moving us closer to the poss...

Long‑acting injectables have reshaped HIV treatment, but they still fall short of overcoming the fundamental limitations of ART. Our latest article explores how next‑generation approaches are moving us closer to the poss...

At ICON, Study Start Up teams play a critical role in accelerating timelines, from site identification and feasibility through to contracting and activation. In this blog, James Pereira shares how leadership in start up...

At ICON, Study Start Up teams play a critical role in accelerating timelines, from site identification and feasibility through to contracting and activation. In this blog, James Pereira shares how leadership in start up...

Attending the World Vaccine Congress? Join ICON’s Dinah Knotts-Keeterle as she discusses ‘AI and the future of vaccine studies from reaction to readiness’. Learn more on 1 April at 12:10 pm. https://ow.ly/9Uk050Yr8VL

With ADC innovation accelerating across Asia, Europe and the US, regulatory synchronisation has never been more important. ICON’s latest article in BioSpectrum Asia explores why proactive scientific advice, dose optimis...